Epidermal growth factor receptor biology in head and neck cancerKALYANKRISHNA, Shailaja; GRANDIS, Jennifer R.Journal of clinical oncology. 2006, Vol 24, Num 17, pp 2666-2672, issn 0732-183X, 7 p.Article

Molecular Pathways: Context-Dependent Approaches to Notch Targeting as Cancer TherapyEGLOFF, Ann Marie; GRANDIS, Jennifer R.Clinical cancer research (Print). 2012, Vol 18, Num 19, pp 5188-5195, issn 1078-0432, 8 p.Article

Therapies directed against epidermal growth factor receptor in aerodigestive carcinomasKARAMOUZIS, Michalis V; GRANDIS, Jennifer R; ARGIRIS, Athanassios et al.JAMA, the journal of the American Medical Association. 2007, Vol 298, Num 1, pp 70-82, issn 0098-7484, 13 p.Article

Integration of molecular targeted therapy with radiation in head and neck cancerYU DU; PEYSER, Noah D; GRANDIS, Jennifer R et al.Pharmacology & therapeutics (Oxford). 2014, Vol 142, Num 1, pp 88-98, issn 0163-7258, 11 p.Article

Response to Combined Molecular Targeting: Defining the Role of P-STAT3EGLOFF, Ann Marie; GRANDIS, Jennifer R.Clinical cancer research (Print). 2011, Vol 17, Num 3, pp 393-395, issn 1078-0432, 3 p.Article

Molecular mediators of metastasis in head and neck squamous cell carcinomaHOWELL, Gina M. S; GRANDIS, Jennifer R.Head & neck. 2005, Vol 27, Num 8, pp 710-717, issn 1043-3074, 8 p.Article

Targeting Epidermal Growth Factor Receptor and Src Pathways in Head and Neck CancerEGLOFF, Ann Marie; GRANDIS, Jennifer R.Seminars in oncology. 2008, Vol 35, Num 3, pp 286-297, issn 0093-7754, 12 p.Article

New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor InhibitorsCHEN, Lucy F; COHEN, Ezra E. W; GRANDIS, Jennifer R et al.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2489-2495, issn 1078-0432, 7 p.Article

Head and Neck CancerVOKES, Everett E; COHEN, Ezra E. W; GRANDIS, Jennifer R et al.Seminars in oncology. 2008, Vol 35, Num 3, issn 0093-7754, 129 p.Serial Issue

Standard and Emerging Therapeutic Approaches for Thyroid MalignanciesBROWN, Rebecca L.Seminars in oncology. 2008, Vol 35, Num 3, pp 298-308, issn 0093-7754, 11 p.Article

EMERGING PERSPECTIVES IN EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING IN HEAD AND NECK CANCERKIM, Seungwon; GRANDIS, Jennifer R; RINALDO, Alessandra et al.Head & neck. 2008, Vol 30, Num 5, pp 667-674, issn 1043-3074, 8 p.Article

Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cellsYAZBECK, Victor Y; CHANGYOU LI; GRANDIS, Jennifer R et al.Oral oncology (1997). 2014, Vol 50, Num 2, pp 120-127, issn 1368-8375, 8 p.Article

Screening for Head and Neck Cancer in Liver Transplant Candidates: A Review of 11 Years of Experience at the University of PittsburghDEDHIA, Raj C; GRANDIS, Jennifer R; FONTES, Paulo A et al.The Laryngoscope. 2012, Vol 122, Num 3, pp 539-542, issn 0023-852X, 4 p.Article

EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED THERAPY OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKSHARAFINSKI, Mark E; FERRIS, Robert L; FERRONE, Soldano et al.Head & neck. 2010, Vol 32, Num 10, pp 1412-1421, issn 1043-3074, 10 p.Article

c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-MetSTABILE, Laura P; GUOQING HE; YAN LUI, Vivian Wai et al.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 380-392, issn 1078-0432, 13 p.Article

Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell CarcinomaWHEELER, Sarah; SIWAK, Doris R; ARGIRIS, Athanassios et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2278-2289, issn 1078-0432, 12 p.Article

Induction Therapy in the Modern Era of Combined-Modality Therapy for Locally Advanced Head and Neck CancerPOSNER, Marshall; VERMORKEN, Jan B.Seminars in oncology. 2008, Vol 35, Num 3, pp 221-228, issn 0093-7754, 8 p.Article

New Developments in Radiation Therapy for Head and Neck Cancer : Intensity-Modulated Radiation Therapy and Hypoxia TargetingLEE, Nancy Y; LE, Quynh-Thu.Seminars in oncology. 2008, Vol 35, Num 3, pp 236-250, issn 0093-7754, 15 p.Article

Salivary Gland Malignancies : The Role for Chemotherapy and Molecular Targeted AgentsSURAKANTI, Sujani G; AGULNIK, Mark.Seminars in oncology. 2008, Vol 35, Num 3, pp 309-319, issn 0093-7754, 11 p.Article

Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFRJUN WANG; XIN ZHANG; THOMAS, Sufi M et al.Oncogene (Basingstoke). 2005, Vol 24, Num 38, pp 5897-5904, issn 0950-9232, 8 p.Article

Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic StudySABA, Nabil F; HURWITZ, Selwyn J; GRIST, William et al.Cancer prevention research (Philadelphia, Pa.). 2014, Vol 7, Num 3, pp 283-291, issn 1940-6207, 9 p.Article

Erlotinib, Erlotinib-Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck CancerGROSS, Neil D; BAUMAN, Julie E; CONRADS, Thomas P et al.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3289-3298, issn 1078-0432, 10 p.Article

Childhood passive smoke exposure is associated with adult head and neck cancerTROY, Jesse D; GRANDIS, Jennifer R; YOUK, Ada O et al.Cancer epidemiology (Print). 2013, Vol 37, Num 4, pp 417-423, issn 1877-7821, 7 p.Article

Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancerTROY, Jesse D; WEISSFELD, Joel L; DIERGAARDE, Brenda et al.Cancer epidemiology (Print). 2013, Vol 37, Num 4, pp 505-511, issn 1877-7821, 7 p.Article

TMEM16A Induces MAPK and Contributes Directly to Tumorigenesis and Cancer ProgressionDUVVURI, Umamaheswar; SHIWARSKI, Daniel J; SCHREIBER, Rainer et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 13, pp 3270-3281, issn 0008-5472, 12 p.Article